Multicenter experience with the antegrade fenestration and reentry technique for chronic total occlusion

Lorenzo Azzalini1,2, Khaldoon Alaswad3, Barry F Uretsky4

  • 1The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Insights

Antegrade fenestration and reentry (AFR) shows moderate success for chronic total occlusion (CTO) recanalization. This technique is safe and does not prevent alternative methods if initial attempts fail.

Area of Science:

  • Cardiovascular Interventions
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Antegrade dissection/reentry (ADR) adoption for chronic total occlusion (CTO) recanalization is limited.
  • Novel ADR techniques are needed to improve CTO recanalization rates.
  • Antegrade fenestration and reentry (AFR) is a novel ADR technique.

Purpose of the Study:

  • To evaluate the efficacy and safety of antegrade fenestration and reentry (AFR) for CTO recanalization.
  • To assess AFR success, procedural success, and target-lesion failure (TLF) in a multicenter registry.
  • To determine the feasibility of AFR in complex CTO cases.

Main Methods:

  • A multicenter registry included patients undergoing AFR-based CTO recanalization.
  • AFR involves creating fenestrations between false and true lumens, followed by guidewire reentry.
  • Study endpoints included AFR success, procedural success, and 1-year TLF.

Main Results:

  • AFR achieved distal true lumen reentry in 65.9% of cases.
  • Overall technical and procedural success rates were 85.4% and 82.9%, respectively.
  • No AFR-related complications were observed; 1-year TLF was 8.3%.

Conclusions:

  • AFR demonstrates feasibility and a moderate success rate for CTO recanalization.
  • The technique is safe, and failed attempts do not preclude alternative recanalization strategies.
  • Further studies are warranted to confirm and extend these findings.
Abstract

Related Concept Videos